Clinical applicability of functional hemodynamic monitoring by García, Xaime & Pinsky, Michael R
REVIEW Open Access
Clinical applicability of functional hemodynamic
monitoring
Xaime García and Michael R Pinsky
*
Abstract
Recent interest in functional hemodynamic monitoring for the bedside assessment of cardiovascular insufficiency
has heightened. Functional hemodynamic monitoring is the assessment of the dynamic interactions of
hemodynamic variables in response to a defined perturbation. Accordingly, fluid responsiveness can be predicted
in a quantities fashion by measuring as arterial pulse pressure variation and left ventricular stroke volume variation
during positive pressure breathing or the change in cardiac output response to a passive leg raising maneuver.
However, volume responsiveness, though important, reflects only part of the overall spectrum of functional
physiological variables that can be measured to define physiologic state and monitor response to therapy.
Dynamic tissue O2 saturation (StO2) responses to complete stop flow conditions, which can be created by
measuring hand StO2 and occluding flow with a blood pressure cuff, assesses cardiovascular sufficiency and
microcirculatory blood flow distribution. Furthermore, these measures can be made increasingly more sensitive and
specific if coupled to other “traditional” measures of organ perfusion, such as blood lactate levels.
Introduction
Recently, increased interest in a more proactive use of
monitoring technologies has emerged, using the
response to the measured variables to a defined stress to
unveil the physiological state of the subject. This entire
field when applied to the assessment of cardiovascular
state is referred to as functional hemodynamic monitor-
ing. Within this context, we can define functional hemo-
dynamic monitoring as the assessment of the dynamic
interactions of hemodynamic variables in response to a
defined perturbation [1]. Such dynamic responses result
in emergent parameters of these commonly reported
variables that greatly increase the ability of these mea-
sures to define cardiovascular state and predict response
to therapy. At the present time, the primary types of
functional hemodynamic monitoring for which clinical
trials have shown clinical usefulness are related to pre-
dicting volume responsiveness and identifying occult
cardiovascular insufficiency (compensated shock). The
primary form of this approach, predicting volume
responsiveness, was reviewed recently in this journal, so
will only be briefly described in this article. However,
like any form of monitoring parameter, its sensitivity
and specificity improves if its pretest probability is
higher. Thus, a fundamental concept often ignored by
proponents of functional hemodynamic monitoring
approaches is the integration of other clinical variables,
such as the clinical condition, serum lactate levels, etc.,
a priori into the decision analysis of cardiovascular
instability and its response to therapy. In essence, func-
tional hemodynamic monitoring, though profoundly
insightful in its values, is only another parameter that
needs to be integrated into the greater view of patient
care if its use is to realize its full potential.
Predicting volume responsiveness
A primary resuscitation question is whether the patient
will increase their cardiac output in response to intra-
vascular volume infusion. Volume responsiveness has
been arbitrarily defined as ≥15% in cardiac output in
response to a 500-ml bolus fluid challenge. Although
the presence of fluid responsiveness in a subject does
not equate for the need to give fluids, it does define that
if fluids are infused cardiac output will increase. Many
studies have validated, during recent years, the useful-
ness of some methods that give the clinician the ability
to predict whether a patient is going to respond to the
volume infusion as a primary step of the hemodynamic
resuscitation. Some of the most commonly used
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output during positive pressure ventilation, such pulse
pressure variation (PPV) and stroke volume variation
(SVV). During the inspiratory phase of positive pressure
ventilation, intrathoracic pressure increases passively,
increasing right atrial pressure and causing venous
return to decrease, decreasing right ventricular output,
and after two or three heart beats, left ventricular out-
put if both ventricles are volume responsive [2]. Thus,
in preload-dependent patients cyclic changes in left ven-
tricular stroke volume and its coupled arterial pulse
pressure are seen and the magnitude of the changes is
proportional to volume responsiveness. The associated
SVV and PPV are quantified in various ways depending
on whether these are measured by minimally invasive
cardiac output monitors (e.g., PiCCO, LiDCO, FloTrac)
or by direct examination of the pressure or flow profiles.
In general both are defined as the ratio of the maximal
minus the minimal values to the mean values, usually
averaged over 3 or more breaths. Numerous studies
have documented that a SVV >10% or a PPV >13-15%
on a tidal volume of 8 ml/kg or greater is highly predic-
tive of volume responsiveness [2-4].
Although powerful diagnostic tools, these parameters
are highly dependent on the cyclic changes in intrathor-
acic pressure being regular and great enough to alter
central venous pressure. Thus, tidal volumes of ≤6m l /
kg or the imposition of variable spontaneous inspiratory
efforts often result in false-negative PPV and SVV
values. Moreover, all of these techniques assume a fixed
heart rate, so in the setting of atrial fibrillation or fre-
quent premature ventricular contractions, these mea-
sures become inaccurate. In these settings, one can
always perform a passive leg raising maneuver [5].
Fluid therapy is one of the first steps in the goal-directed
therapy in clinical guidelines of hemodynamic resuscitation
of patients in shock [6,7]. Thus, an adequate assessment of
fluid responsiveness should improve the therapy. A study
conducted in high-risk surgery patients showed that volume
loading guided to the goal of PPV minimization improves
postoperative outcome and decreases length of hospital stay
[8]. Patients in the interventional group received more fluid
than the control group and had less postoperative compli-
cations, lower duration of mechanical ventilation, and
shorter stay in the intensive care unit. Similarly, Pearse et
al. [9] conducted a study to evaluate the effect of postopera-
tive goal-directed therapy in postoperative high-risk
patients. Targeting an oxygen delivery index > 600 mL/kg/
min, they were able to reduce both postoperative complica-
tions and median duration of hospital stay.
Identification of cardiovascular insufficiency
Cardiovascular insufficiency is characterized by an
inadequate O2 delivery relative to the metabolic
demands. Shock can be, in the early stages, compensated
by autonomic mechanisms, such regional vasoconstric-
tion, in an attempt to maintain central blood pressure
and vital organ perfusion above an anaerobic threshold.
In this stage of compensated shock, microcirculatory
measures, such as arterial pressure or cardiac output
often are inside the range of values defined as normal
and, therefore, insensitive as early predictors of subse-
quent decompensation due to the increased risk of tis-
sue ischemia and subsequent development of
multiorgan failure and death. However, microcirculation
alterations in muscle and skin blood flow already occur
during these early stages and measures of tissue cardio-
vascular reserve should be a sensitive early warning
measure of impending cardiovascular collapse. Thus, a
valid method to assess the microcirculatory status, such
as the noninvasive measurement of tissue oxygen satura-
tion (StO2) when coupled with a functional hemody-
namic monitoring test, such as the vascular occlusion
test (VOT), may allow early identification of compen-
sated circulatory shock and thus guide initial resuscita-
tion efforts.
Noninvasive measurement of StO2 using near-infra-
red spectroscopy has been shown as a valid method to
assess the microcirculation status, especially in septic
a n dt r a u m ap a t i e n t s .T h ea b s o l u t eS t O 2 value has a
limited discriminating capacity because StO2 remains
within the normal range until shock is quite advanced.
But the addition of a dynamic ischemic challenge, such
as the VOT, improves and expands the predictive abil-
ity of StO2 to identify tissue hypoperfusion [10]. The
VOT measures the effect of total vascular occlusion-
i n d u c e dt i s s u ei s c h e m i aa n dr e l e a s eo nd o w n s t r e a m
StO2.S t O 2 is measured on the thenar eminence and
transient rapid vascular occlusion of the arm by sphyg-
momanometer inflation to 30 mmHg above systolic
pressure is performed either for a defined time inter-
val, usually 3 min, or until StO2 declines to some
threshold minimal value, usually 40%. The deoxygena-
tion rate (DeO2) reflects the local metabolic rate and
mitochondrial function, and the rate of reoxygenation
rate (ReO2) reflects local cardiovascular reserve and
microcirculatory flow.
There is strong evidence for microcirculatory failure
during shock to be a major component of the end-organ
dysfunction seen. Such microcirculatory dysfunction can
be characterized by oxygen shunting, vasoconstriction,
thrombosis, and tissue edema. As a result of these com-
bined microcirculatory events, the flow distribution
within the tissue is impaired [11]. It has been shown
that these microcirculatory alterations improve rapidly
in septic shock survivors, whereas patients dying by
organ failure have a lower percentage of perfused small
vessels [12].
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response are related to the outcome has been proved in
patients with severe sepsis or septic shock by Creteur et
al. [13]. Furthermore, when comparing hemodynamically
stable patients without infection (controls) and healthy
volunteers, these differences in the septic patients were
striking. Using near-infrared spectroscopy VOT StO2,
they assessed the slope of increase in StO2 release as
w e l la st h ed i f f e r e n c eb e t w e e nt h em a x i m u mS t O 2 and
the StO2 baseline (Δ). Both the slope of ReO2 and the Δ
were significantly lower in septic patients than in con-
trol subjects and healthy volunteers. In the sample of
septic patients, the slopes also were significantly lower
in the ones who had cardiovascular insufficiency. ReO2
slopes were higher in survivors than in nonsurvivors
and also tended to increase during resuscitation in sur-
vivors but not in nonsurvivors. Finally, the ReO2 slope
was found to be a good predictor of ICU death, with a
cutoff value of 2.55%/sec (sensitivity 85%, specificity
73%). These data confirm that the alterations in VOT
StO2 ReO2 are related more to the sepsis process itself
and its severity than to mean arterial pressure or vaso-
pressor agent’s dose. Importantly, the magnitude of this
ReO2 slope alteration is directly related to the septic dis-
ease and their presence in the first 24 hours of septic
process and their persistence of delayed ReO2 slope is
related to the patient’s outcome. Still, if the StO2 ReO2
does reflect inadequate tissue perfusion then it also
should be sensitive of an impending cardiovascular
insufficiency state (compensated shock) if matched with
other static measures of tissue ischemia.
To address this issue, Guyette et al. [14] measured
both the VOT StO2 as baseline serum lactate, known to
define existing cardiovascular insufficiency in trauma, in
ac o h o r to ft r a u m ap a t i e n t sd u r i n gt h ea i rt r a n s p o r tt o
the Trauma Center. This study was designed to deter-
mine whether the StO2 measurement, including a VOT,
was feasible in the prehospital environment and useful
to predict in-hospital death and intensive care unit
(ICU) admission. Not surprisingly, they did not find dif-
ferences in baseline StO2 between survivors, nonsurvi-
vors, and patients admitted to the ICU, and they
showed significant differences in DeO2 and ReO2 slopes
between survivors and nonsurvivors, as well as between
patients who need ICU admission and patients who did
not. Furthermore, only one of the five patient deaths in
their sample had prehospital vitals signs that would have
met the protocolized criteria for resuscitation (heart rate
>120 bpm, systolic blood pressure <90 mmHg). Impor-
tantly, serum lactate alone was no better than lowest
systolic pressure in predicting those in need of life-sav-
ing interventions or death, but if the baseline serum lac-
tate was >1.7 mmol/dl the ReO2 was 100% specific for
the need of life-saving interventions. This study shows
the usefulness of the microcirculation dynamic assess-
ment in the early stages of the trauma injury, when car-
diovascular insufficiency is not suspected with the
macrocirculatory indexes, providing the possibility to
start early the appropriate treatment and decide the in-
hospital disposition.
These studies show that microcirculation status, mea-
sured by a dynamic test, such the StO2 VOT, can be
more accurate than the microcirculatory and static clas-
sic values assessing the cardiovascular insufficiency in
patients with shock. A study conducted by Vallée et al.
[15] proved the hypothesis that in septic patients when
the goal of the resuscitation bundles (central venous
oxygen saturation (SvcO2) >70%) has been already
achieved, an index of tissue perfusion, such as the
venous-to-arterial carbon dioxide difference [P(cv-a)
CO2], could be useful to identify those patients who still
were inadequately resuscitated. Patients with [P(cv-a)
CO2] higher than 6 mmHg had a lower cardiac index, a
larger clearance of lactate, and a slower decrease of
SOFA score in the first 24 h than patients with a [P(cv-
a)CO2] lower than 6 mmHg [15].
The presence of cardiovascular insufficiency in
patients with shock also can be assessed by metabolic
products, such as lactate or strong ion difference (SID).
The early presence of high levels of plasma lactate is
associated with higher in-hospital mortality in patients
presenting with circulatory shock [16,17]. Moreover,
those patients who are able to decrease their lactate
levels with the hemodynamic resuscitation procedures
have a better outcome than those who are not. Thus, it
would be reasonable to target lactate levels as an end-
point of the hemodynamic resuscitation interventions as
a way to early know when a patient is being correctly
resuscitated. A trial that focused on reaching a SvcO2
>70% and lactate concentration ≤2 mmol/L by improv-
ing the oxygen delivery in postsurgical patients whose
lactate levels were high or did not decrease showed a
shorter hospital stay and lower morbidity [18]. A more
recent study by Jones et al. [19] focused on comparing
two early sepsis resuscitation protocols: one was
designed to normalize central venous pressure (CVP),
mean arterial pressure (MAP), and lactate clearance of
at least 10%, and another with SvcO2 as a goal, as well
as CVP and MAP, showed no difference for in-hospital
mortality.
In addition to the creation of lactate, tissue hypoperfu-
sion due to cardiovascular insufficiency induces forma-
tion of anions as results of anaerobic metabolism and,
finally, acidosis. The anion gap and, especially, the SID
calculated as the difference between fully dissociated
anions and cations, may help to evaluate those cases of
metabolic disorders with acidosis adding the possibility
to quantify the contribution of each metabolic disorder
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based on the principles described by Stewart [20], pro-
poses the SID, as one of the three factors (together with
the total weak acid difference and the PaCO2) that inde-
pendently determine the pH. It has been proven that
the SID is useful to identify patients with major acid-
base disturbances even when the standard base excess is
normal [21]. Nevertheless, it has not been reflected in
superiority against standard base excess predicting mor-
tality, nor tested as goal of directed therapy in shock
patients [21,22].
Conclusions
Functional hemodynamic monitoring is the pluripoten-
tial approach to interpolation of physiological data in a
proactive form. It has acquired a strong foothold in
assessment of volume responsiveness for the manage-
ment of the critically ill patient, showing a high applic-
ability in shock resuscitation, but needs to be considered
within the broader aspects of risk stratification to reach
its full potential. Because early goal-directed therapy
algorithms need to resuscitate to circulatory sufficiency,
defining endpoints become as important as defining
treatments to initiate. This field is rapidly expanding
and has potential application for assessment of regional
perfusion and function and across all acute care
disciplines.
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